“For patients seeking noticeable results, whether it's improved skin texture, better sleep, enhanced metabolism or muscle ...

FDA approves Novo Nordisk's Alhemo for hemophilia A and B without inhibitors, following strong Phase 3 results showing reduced bleeding episodes.

Discover how naturopathic physician Bill Caradonna, R.Ph., ND, uses homeopathic trigger point and subcutaneous injections to ...

Regeneron Pharmaceuticals and Sanofi are collaborating on a Phase 4 clinical study titled ‘A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Dupilum ...

The FDA has approved Skytrofa (lonapegsomatropin-tcgd) for the replacement of growth hormone in adults with GHD.

While Rosie O’Donnell, 63, made a name for herself as a Broadway star and host of the Emmy-winning talk show The Rosie ...

An expert discusses how home administration of oncology drugs in the US faces significant logistical and reimbursement ...

KalVista Pharmaceuticals faces a shrinking HAE market, tough competition, and launch uncertainty despite FDA approval. Read ...

Ascendis’ likely approval of TransCon CNP for achondroplasia poses a major threat to BioMarin’s best-selling drug. Read why I'm downgrading BMRN stock to Hold.

BD (NYSE:BDX) today announced the first pharma-sponsored combination product clinical trial using its wearable injector ...

Panelists discuss how subcutaneous (SubQ) and intravenous (IV) oncology therapies will continue to coexist, with ...